COSMOS Pharmaceutical Corporation (3349)

Name: COSMOS Pharmaceutical Corporation (3349) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-30

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products.

Dati chiave

Capitalizzazione di mercato: JPY 488 billion
Ricavi (esercizio chiuso a 2026-05-31): JPY 1.10T
Utile netto: JPY 32.0B
Margine lordo: 20.9%
Margine netto: 2.9%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31
Entrate totali	JPY 1.10T	JPY 1.01T	JPY 965.0B	JPY 827.7B	—
Utile lordo	JPY 229.7B	JPY 213.3B	JPY 188.3B	JPY 168.7B	—
Risultato Operativo (EBIT)	JPY 42.4B	JPY 40.4B	JPY 31.5B	JPY 30.1B	—
Reddito netto	JPY 32.0B	JPY 31.0B	JPY 24.5B	JPY 23.8B	—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 3349. /companies/us/3349

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.